Staging and evaluation of gestational trophoblastic disease

Clinical Obstetrics and Gynecology

Volumn 46, Issue 3, 2003, Pages 570-578

  Soper, John T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; BRAIN METASTASIS; CANCER CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVALUATION; FEMALE; HUMAN; INTERNATIONAL COOPERATION; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; SCORING SYSTEM; TROPHOBLASTIC DISEASE; TUMOR LOCALIZATION; VAGINA CANCER;

CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; PREGNANCY; UTERINE NEOPLASMS;

EID: 0141787124     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200309000-00008     Document Type: Conference Paper

References (23)

1. Soper JT, Lewis JL Jr, Hammond CB. Gestational Trophoblastic Disease. In Hoskins WJ, Perez CA, Young RC (eds): Principles and Practice of Gynecologic Oncology, 2nd Edition. Philadelphia, Lippincott-Raven, 1996; pp 1039-1077
2. Tidy JA, Rustin GJ, Newlands ES, et al. Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynaecol. 1995;102:715-719.
3. Delfs E. Chorionic gonadotropin determinations with hydatidiform mole and choriocarcinoma. Ann N Y Acad Sci. 1957;80:125-139.
4. Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-83. Lancet. 1986;2:673-677.
5. Kohorn EI. Criteria toward the definition of nonmetastatic trophoblastic disease after hydatidiform mole. Am J Obstet Gynecol. 1982;145:591-595.
6. Schlaerth JB, Morrow CP, Nalick RH, et al. Single-dose actinomycin D in the treatment of trophoblastic disease. Gynecol Oncol. 1984;19:53-56.
7. Kohorn EI, Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol. 1993;48:139-147.
8. Hertz R, Ross GT, Lipsett MB. Primary chemotherapy for nonmetastatic choriocarcinoma in women. Am J Obstet Gynecol. 1963;86:808-814.
9. Kohom EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2000;11:73-77.
10. Cole. LA. Phantom hCG and phantom choriocarcinoma. Gynecol Oncol. 1998;71:325-329.
11. Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet. 2000;355:712-715.
12. Soper JT, Clarke-Pearson DL, Hammond CB. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients. Obstet Gynecol. 1988;71:338-343.
13. Hunter V, Raymond E, Christensen C, et al. Efficacy of the metastatic survey in the staging of gestational trophoblastic disease. Cancer. 1990;65:1647-1650.
14. Mutch DG, Soper JT, Baker ME, et al. Role of computed axial tomography of the chest in staging patients with non-metastatic gestational trophoblastic disease. Obstet Gynecol. 1986;68:348-352.
15. Ngan HY, Chan FL, Au VW, et al. Clinical outcome of micrometastasis in the lung in stage IA persistent gestational trophoblastic disease. Gynecol Oncol. 1998;70:192-194.
16. Ross GT, Goldstein DP, Hertz R, et al. Sequential use of methotrexate and actinomycin-D in the treatment of choriocarcinoma and related trophoblastic diseases in women. Am J Obstet Gynecol. 1965;93:223-229.
17. Hammond CB, Borchert LG, Tyrey L, et al. Treatment of metastatic gestational trophoblastic disease. Good and poor prognosis. Am J Obstet Gynecol. 1973;115:451-457.
18. World Health Organization Scientific Group. Gestational trophoblastic disease. Technical report series 692. Geneva, Switzerland, World Health Organization, 1983
19. Bagshawe KD. Risk and prognostic factors in trophoblastic disease. Cancer. 1976;38:1373-1385.
20. Soper JT, Evans AC, Conaway MR, et al. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol. 1994;84:969-973.
21. Hancock BW, Welch EM, Gillespie AM, et al. A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. Int J Gynecol Cancer. 2000;10:318-322.
22. Pettersson F, Kolstad P, Ludwig H, et al. Annual Report on the Results of Treatment of Gynecologic Cancer, vol 19. Stockholm, Sweden, International Federation of Gynecology and Obstetrics, 1985
23. FIGO Ocology Committee. Report. Int J Gynecol Obstet. 1992;39:149-150.